Nanoliposomes for encapsulation and delivery of the potential antitumoral methyl 6-methoxy-3-(4-methoxyphenyl)-1H-indole-2-carboxylate

A potential antitumoral fluorescent indole derivative, methyl 6-methoxy-3-(4-methoxyphenyl)-1H-indole-2-carboxylate, was evaluated for the in vitro cell growth inhibition on three human tumor cell lines, MCF-7 (breast adenocarcinoma), A375-C5 (melanoma), and NCI-H460 (non-small cell lung cancer), after a continuous exposure of 48 h, exhibiting very low GI50 values for all the cell lines tested (0.25 to 0.33 μM). This compound was encapsulated in different nanosized liposome formulations, containing egg lecithin (Egg-PC), dipalmitoyl phosphatidylcholine (DPPC), dipalmitoyl phosphatidylglycerol (DPPG), DSPC, cholesterol, dihexadecyl phosphate, and DSPE-PEG. Dynamic light scattering measurements showed that nanoliposomes with the encapsulated compound are generally monodisperse and with hydrodynamic diameters lower than 120 nm, good stability and zeta potential values lower than -18 mV. Dialysis experiments allowed to monitor compound diffusion through the lipid membrane, from DPPC/DPPG donor liposomes to NBD-labelled lipid/DPPC/DPPG acceptor liposomes.     

One-Pot Three-Component Synthesis of Novel Diethyl((2-oxo-1,2-dihydroquinolin-3-yl)(arylamino)methyl)phosphonate as Potential Anticancer Agents

With the aim of discovering new anticancer agents, we have designed and synthesized novel α-aminophosphonate derivatives containing a 2-oxoquinoline structure using a convenient one-pot three-component method. The newly synthesized compounds were evaluated for antitumor activities against the A549 (human lung adenocarcinoma cell), HeLa (human cervical carcinoma cell), MCF-7 (human breast cancer cell), and U2OS (human osteosarcoma cell) cancer cell lines in vitro, employing a standard 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) assay. The results of pharmacological screening indicated that many compounds exhibited moderate to high levels of antitumor activities against the tested cancer cell lines and that most compounds showed more potent inhibitory activities comparable to 5-fluorouracil (5-FU) which was used as a positive control. The mechanism of representative compound 4u (diethyl((2-oxo-1,2-dihydroquinolin-3-yl)(phenyl-amino)methyl)phosphonate) indicated that the compound mainly arrested HeLa cells in S and G2 stages and was accompanied by apoptosis in HeLa cells. This action was confirmed by acridine orange/ethidium bromide staining, Hoechst 33342 staining, and flow cytometry.     

11βHSD1抑制剂1-(4-氟苯甲酰基)-4-(4-三氟甲氧基苯甲酰基)哌啶的合成

以4-甲氧羰基哌啶盐酸盐(2)和氟苯甲酰氯(3)为起始原料,在三乙胺的作用下以93.5%的收率制得化合物4;化合物4甲醇水溶液,在弱碱氢氧化锂作用下,以97.8%的收率水解为化合物5;化合物5在羰基二咪唑与N-甲基-N-甲氧基盐酸盐(6)作用,以94.6%的收率制得化合物7;化合物7和4-三氟甲氧基苯基溴化镁(8)偶联,以71.8%的收率制得化合物1。四步反应总收率62.1%。     

1-(4-三氟甲氧基苯甲酰基)-4-(4-甲氧基苯甲酰基)哌啶的合成研究

以4-甲氧羰基哌啶盐酸盐(2)和对三氟甲氧基苯甲酰氯(3)为起始原料,在三乙胺的作用下以92.7%的收率制得化合物(4);化合物(4)甲醇水溶液中,在弱碱氢氧化锂作用下,以95.4%的收率水解为化合物(5);化合物(5)在羰基二咪唑与N-甲基-N-甲氧基盐酸盐作用,以94.2%的收率制得化合物(6);化合物(6)和4-甲氧基苯基溴化镁偶联,以60.1%的收率制得化合物(1)。4步反应总收率50.0%。     

Synthesis of Combretastatin-A4 Carboxamidest that Mimic Sulfonyl Piperazines by a Molecular Hybridization Approach: in vitro Cytotoxicity Evaluation and Inhibition of Tubulin Polymerization

Molecular hybridization approach is a promising structural modification tool to design new chemical entities (NCEs) by mimicking two different pharmacophoric units into one scaffold to enhance the biological properties. With this aim, combretastatin-A4 acids were integrated with sulfonyl piperazine scaffolds as a one molecular platform and evaluated for their in vitro antiproliferative activity against a panel of human cancer lines cell lines namely, lung (A549), mouse melanoma (B16F10), breast (MDA MB-231and MCF-7) and colon (HCT-15) by MTT assay. Amongst which the compound (E)-3-(4-Chlorophenyl)-1-(4-((4-chlorophenyl)sulfonyl)piperazin-1-yl)-2-(3,4,5-trimethoxyphenyl)prop-2-en-1-one ( 5 ab ) displayed significant IC₅₀ values in the range of 0.36 to 7.08 μm against the selected cancer cell lines. Moreover, 5 ab was found to be the most potent member of this series with IC₅₀ 0.36±0.02 μm . Further investigations revealed that the compound 5 ab displayed significant inhibition of tubulin assembly with IC₅₀ 5.24±0.06 μm and molecular docking studies also disclosed the binding of 5 ab effectively in CA4 binding space at the colchicine binding site. The flow cytometric analysis demonstrated that the compound 5 ab caused cell cycle arrest at G2/M phase in A549 cells. Compound 5 ab induced apoptosis in A549 cells which was further evaluated by different staining assays such as DAPI and AO which undoubtedly speculated, the induction of apoptosis. To study the anti-migration with 5 ab , cell migration/scratch wound assay was performed and the extent of apoptosis was studied by Annexin-V, including mitochondrial potential by JC-1 staining.     

5-对羧基苯基-10,15,20-三间羟基苯基二氢卟吩-PEG-叶酸的设计与合成

以聚乙二醇二胺、叶酸、5-对羧基苯基-10,15,20-三间羟基苯基二氢卟吩为原料,合成了2个光敏化合物:5-对羧基苯基-10,15,20-三间羟基苯基二氢卟吩-PEG-叶酸(3a)和5-对羧基苯基-10,15,20-三间羟基苯基二氢卟吩-PEG-NHBoc(3b),其结构经UV、IR、HPLC、1H MNR和MS确认。采用L9(33)正交实验法优化目标物3a的合成条件,在n(DCC)∶n(卟吩)=2∶1、反应温度为50℃、反应时间为5d时,3a收率最好。     

11βHSD1抑制剂1-(4-三氟甲氧基苯甲酰基)-4-(4-甲氧基苯甲酰基)哌啶的合成研究

以4-甲氧羰基哌啶盐酸盐(1)和对三氟甲氧基苯甲酰氯(2)为起始原料,在三乙胺的作用下以92.7%的收率制得1-(4-三氟甲基苯甲酰基)-4-甲氧羰基哌啶(3);化合物(3)在羰基二咪唑与N,O-二甲基羟胺盐酸盐(4)作用下,以89.9%的收率制得1-(4-三氟甲氧基苯甲酰基)-4-(N-甲基-N-甲氧基羰基)哌啶(5);化合物(5)和4-甲氧基苯基溴化镁(6)偶联,以60.1%的收率制得化合物1-(4-三氟甲氧基苯甲酰基)-4-(4-甲氧基苯甲酰基)哌啶(7)。三步反应总收率50.0%。     

1-(5,6-亚甲二氧基吲哚-2-甲酰基)-4-苄基哌嗪的合成

以左旋多巴为起始原料经氧化环合得到5,6-二羟基吲哚甲酸,再将羧基酯化保护、儿茶酚保护后得到目标化合物的母核,后经酸性水解和HOBt-EDCI催化形成活性酯中间体后,与N-苄基哌嗪缩合,得到目标化合物。其结构经1H NMR和MS确证。     

Synthesis and cytotoxicity of enantiomerically pure [1,2-diamino-1-(4-fluorophenyl)-3-methylbutane]platinum(II) complexes

A series of leaving group derivatives of enantiomerically pure [1,2-diamino-1-(4-fluorophenyl)-3-methylbutane]platinum(II) complexes were synthesized and tested for cytotoxicity. The enantiomeric purity was determined by 1H NMR spectroscopy on the final diamines after derivation with (1R)-myrtenal. For coordination to platinum, the diamines were reacted with K2PtI4. The treatment of diiodoplatinum(II) complexes (4F-Ph/iProp-PtI2) with Ag2SO4 resulted in the sulfatoplatinum(II) complexes (4F-Ph/iProp-PtSO4), which can be easily transformed to dichloroplatinum(II) complexes (4F-Ph/iProp-PtCl2) with 2 n HCl. The importance of the leaving groups and the configuration at the diamine ligand on the antiproliferative effects was evaluated on the hormone-dependent MCF-7 and the hormone-independent MDA-MB 231 breast cancer cell lines as well as the LNCaP/FGC prostate cancer cell line. (R,R)-4F-Ph/iProp-PtCl2 was identified as the most active platinum(II) complex. The 3-methyl group increased antiproliferative effects relative to the [1,2-diamino-1-(4-fluorophenyl)butane]platinum(II) complexes described in an earlier study.     

1-(3-氯苯基)-4-(3-氯丙基)哌嗪盐酸盐的合成

3-氯苯胺与双-(2-氯乙基)胺盐酸盐反应生成1-(3-氯苯基)哌嗪,再与1-溴-3-氯丙 烷反应生成1-(3-氯苯基)-4-(3-氯丙基)哌嗪,成盐得1-(3-氯苯基)-4-(3-氯丙基)哌嗪盐酸盐,总 收率45．7％。     

Development of Isatin-Based Schiff Bases Targeting VEGFR-2 Inhibition: Synthesis,Characterization, Antiproliferative Properties,and QSAR Studies

Three sets of isatin-based Schiff bases were synthesized utilizing the molecular hybridization approach. Some of the synthesized Schiff bases show significant to moderate antiproliferative properties against MCF7 (breast), HCT116 (colon), and PaCa2 (pancreatic) cancer cell lines with potency compared to reference drugs 5-fluorouracil (5-FU) and Sunitinib. Among all, compound 17 f (3-((1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)imino)-1-((1-(2-methoxyphenyl)-1H-1,2,3-triazol-4-yl)methyl)-5-methylindolin-2-one) exhibits promising antiproliferative properties against the MCF7 cancer cell line with 2.1-fold more potency than Sunitinib. However, among all the synthesized compounds, three (5-methylisatin derivatives) were the most effective against HCT116 in comparison to 5-FU. Compound 17 f exhibited the highest anti-angiogenic effect on the vasculature as it significantly reduced BV from 43 mm to 2 mm in comparison to 5.7 mm for Sunitinib and flow cytometry supports the arrest of the cell cycle at G1/S phases. In addition, compound 17 f also showed high VEGFR-2 inhibition properties against breast cancer cell lines. Robust 2D-QSAR studies supported the biological data.     

Crystal structures of 2-aminotropone, n,n'-di(tropon-2-yl)piperazine, and 5-(4-ethoxyphenylazo)tropolone

Crystal structures of 2-aminotropone (1), N,N'-di(tropon-2-yl)piperazine (2), and 5-(4-ethoxyphenylazo)tropolone (3) have been elucidated by X-crystallographic analysis. 2-Aminotropone (1) contains three crystallographically independent molecules in the crystal lattice. The NH2 groups of 2-aminotropone unit of 1 participate in the N-H...O intermolecular hydrogen bonds. Two tropone units of N,N'-di(tropon-2-yl)piperazine (2) have an anti orientation to the piperazine ring. The crystal packing of 2 is consolidated by pi...pi, C-H...pi, and C-H...O interactions. 5-(4-Ethoxyphenylazo)tropolone (3) forms O-H...O hydrogen bond dimmers about inversion centres, involving the OH group and an intermolecular carbonyl O acceptor.     

2-{5-[(Z,2Z)-2-Chloro-3-(4-nitrophenyl)-2-propenylidene]-4-oxo-2-thioxothiazolidin-3-yl}-3-methylbutanoic Acid as a Potential Anti-Breast Cancer Molecule

It was established that the synthesis of hybrid molecules containing a thiazolidinone and a (2Z)-2-chloro-3-(4-nitrophenyl)prop-2-ene structural fragments is an effective approach for the design of potential anticancer agents. Given the results of the previous SAR-analysis, the aim of the study was to synthesize a novel 4-thiazolidinone derivative Les-3331 and investigate its molecular mechanism of action in MCF-7 and MDA-MB-231 breast cancer cells. The cytotoxic properties and antiproliferative potential of Les-3331 were determined. The effect of the tested compound on apoptosis induction and mitochondrial membrane potential was checked by flow cytometry. ELISA was used to determine caspase-8 and caspase-9, LC3A, LC3B, Beclin-1, and topoisomerase II concentration. Additionally, PAMPA, in silico or in vitro prediction of metabolism, CYP3A4/2D6 inhibition, and an Ames test were performed. Les-3331 possesses high cytotoxic and antiproliferative activity in MCF-7 and MDA-MB-231 breast cancer cells. Its molecular mechanism of action is associated with apoptosis induction, decreased mitochondrial membrane potential, and increased caspase-9 and caspase-8 concentrations. Les-3331 decreased LC3A, LC3B, and Beclin-1 concentration in tested cell lines. Topoisomerase II concentration was also lowered. The most probable metabolic pathways and no DDIs risk of Les-3331 were confirmed in in vitro assays. Our studies confirmed that a novel 4-thiazolidinone derivative represents promising anti-breast cancer activity.     

LSD1小分子抑制剂的合成及抗肿瘤活性研究

设计并合成了一系列以苯甲酰肼类结构为母核的赖氨酸特异性组蛋白去甲基化酶1(LSD1)小分子抑制剂,并研究其体外抗肿瘤活性。首先,通过体外酶水平单浓度抑制实验进行了初步评价,并随后进一步考察目标化合物对多种LSD1高表达肿瘤细胞株增殖的抑制作用,化合物结构经质谱及核磁共振表征确证。活性评价结果显示,3-(((3R,5S)-3,5-二甲基吗啉代)磺酰基)-N'-(7-羟基-2,3-二氢-1H-茚-1-亚基)苯甲酰肼、N'-(1-(5-氯-2-羟基苯基)亚乙基)-3-(((3R,5S)-3,5-二甲基吗啉代)磺酰基)苯甲酰肼和N'-(4-氯-7-羟基-2,3-二氢-1H-茚-1-亚基)-3-((4-吗啉代哌啶-1-基)磺酰基)苯甲酰肼可显著抑制肿瘤细胞的增殖,并有4个目标化合物对体外多种LSD1高表达的肿瘤细胞株增殖有抑制作用,其中3-(((3R,5S)-3,5-二甲基吗啉代)磺酰基)-N'-(7-羟基-2,3-二氢-1H-茚-1-亚基)苯甲酰肼对BGC823、HCT116、A2780s的半数抑制浓度分别为0.32、0.54、0.90μmol/L。     

S-(4-Methoxyphenyl)-4-methoxybenzenesulfonothioate as a Promising Lead Compound for the Development of a Renal Carcinoma Agent

Organosulfur compounds show cytotoxic potential towards many tumor cell lines. Disulfides and thiosulfonates act through apoptotic processes, inducing proteins associated with apoptosis, endoplasmic reticulum stress, and the unfolded protein response. Three p-substituted symmetric diaryl disulfides and three diaryl thiosulfonates were synthesized and analyzed for inhibition of tubulin polymerization and for human cancer cell cytotoxic activity against seven tumor cell lines and a non-tumor cell line. S-(4-methoxyphenyl)-4-methoxybenzenesulfonothioate ( 6 ) exhibited inhibition of tubulin polymerization and showed the best antiproliferative potential, especially against the 786-0 cell line, being six times more selective as compared with the non-tumor cell line. In addition, compound 6 was able to activate caspase-3 after 24 and 48 h treatments of the 786-0 cell line and induced cell-cycle arrest in the G2/M stage at the highest concentration evaluated at 24 and 48 h. Compound 6 was able to cause complete inhibition of proliferation, inducing the death of 786-0 cells, by increasing the number of cells at G2/M and greater activation of caspase-3.     

Synthesis, Characterization and Antiproliferative Activity of the Co(II), Ni(II), Cu(II), Pd(II) and Pt(II) Complexes of 2-(4-Thiazolyl)Benzimidazole (Thiabendazole)

Complexes of 2-(4-thiazolyi)benzimidazole (thiabendazole, THBD) with Co(II), Ni(II), Cu(ll) of general formula ML(2)(NO(3))(2) H(2)O and complexes of Pd(II) and Pt(II) of general formula ML2Cl(2) H(2)O have been obtained and characterized by elemental analyses, IR and far IR spectroscopy and magnetic measurements. The X-ray crystal structure of the copper(II) complex has been determined. The in vitro cell proliferation inhibitory activity of these compounds was examined against human cancer cell lines A 549 (lung carcinoma), HCV-29 T (urinary bladder carcinoma), MCF-7 (breast cancer), T47D (breast cancer), MES-SA (uterine carcinoma) and HL-60 (promyelocytic leukemia). Pt-THBD has been found to exhibit an antileukemic activity of the HL-60 line cells matching that of an arbitrary criterion.     

1-(4-甲苯基)-3-(4-吲哚基)-5-(4-氯苯基)甲臢的合成

以吲哚-4-甲醛、对甲基苯肼和对氯苯胺为原料,合成了1-(4-甲苯基)-3-(4-吲哚基)-5-(4-氯苯基)甲臢。经红外、核磁和质谱等波谱鉴定了目标分子的结构,并测定了它的氧化还原电位值。     

5-[(4-氨基苯基)二氮烯基]嘧啶-2,4,6(1H,3H,5H)-三酮的合成

以对硝基苯胺和巴比妥酸为原料,通过重氮化及偶合反应合成了5-[(4-硝基苯基)二氮烯基]嘧啶-2,4,6(1H,3H,5H)-三酮(A),化合物A经硫化物还原,得到单偶氮化合物5-[(4-氨基苯基)二氮烯基]嘧啶-2,4,6(1H,3H,5H)-三酮(B),该化合物可作为重氮组分与一些具有活泼氢的偶合组分反应,从而制备出酰胺键多、对称性高及稳定性强的双偶氮化合物。考察了还原剂用量、反应时间及反应温度对化合物B收率的影响,结果表明:投料比n(A)∶n(Na2S)=1∶1.7,105℃下回流48h,化合物B的收率为84.6%。利用1H NMR、FT-IR及元素分析对产物的结构进行了表征。     

阿魏酰哌嗪盐酸盐的合成

目的：合成阿魏酰哌嗪盐酸盐。方法：以阿魏酸为起始原料,对羟基进行乙酰化保护,得到乙酰阿魏酸,经酰氯化后与哌嗪反应得到单取代哌嗪衍生物,除去乙酰基得到目标物。结果与结论：合成得到了阿魏酰哌嗪,目标化合物通过IR,1HNMR和MS等确证,产率为56．9％。